BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Guanabenz

An alpha-2 selective adrenergic agonist used as an antihypertensive agent.

298+ PubMed studies analyzed · 15 RCTs · Evidence Score: 42.3

Research Domains

Guanabenz has been studied across 23 research domains including ❤️ Cardiovascular, 🧘 Stress & Anxiety, 🫘 Kidney, 🧠 Focus & Attention, 🔬 Oncology. The primary research focus is ❤️ Cardiovascular with 33% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Guanabenz, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Oxymetazoline
18 shared targets
Clonidine
16 shared targets
Dexmedetomidine
13 shared targets
Phentolamine
17 shared targets
Yohimbine
18 shared targets
Dihydroergotamine
19 shared targets
Methylergonovine
17 shared targets
Guanfacine
13 shared targets
Trazodone
16 shared targets
Quetiapine
19 shared targets
Loading evidence profile...

This evidence profile for Guanabenz is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.